跳至主要内容
临床试验/NCT01167764
NCT01167764撤回3 期

Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis: Multicenter, Prospective, Randomized, Double-blind Phase 3 Trial

Seoul National University Hospital3 个研究点 分布在 1 个国家开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
试验地点
3
主要终点
the proportion of recurrence of hemoptysis

研究概览

简要总结

Hemoptysis is one of the serious complication of many pulmonary diseases. Upto now, there is no proven medical treatment in recurrence of hemoptysis. The investigators will conduct a randomized, placebo controlled trial of tranexamic acid, which can reduce the recurrence of hemoptysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age: >=20 and <=75
  • ER visit or admission for hemoptysis
  • no evidence of hemoptysis on screening

排除标准

  • anticoagulation treatment
  • Cr >= 2.0 mg/dL or urinary protein >= 2+ or who received renal replacement treatment
  • hepatic failure: total bilirubin >= 1.5 mg/dL or AST or ALT >= 1.5 of upper normal limit level
  • hypersensitivity to tranexamic acid
  • pregnant woman
  • fertile female who don't use contraception

研究组 & 干预措施

tranexamic acid

Active Comparator

tranexamic acid 250mg po 3 times/day for 1 months

干预措施: tranexamic acid, placebo (Drug)

placebo

Placebo Comparator

placebo po 3 times/day for 1 months

干预措施: tranexamic acid, placebo (Drug)

结局指标

主要结局

the proportion of recurrence of hemoptysis

时间窗: 6 month: 1months medication + 5months observation

次要结局

  • time to recurrence(6 month: 1months medication + 5months observation)

研究者

申办方类型
Other

研究点 (3)

Loading locations...

相似试验

Effect of Tranexamic Acid on Prevention of... | 临床试验